Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 November 2003, Vol. 102, No. 10, pp. 3727-3736.
Prepublished online as a Blood First Edition Paper on July 31, 2003; DOI 10.1182/blood-2003-02-0412.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-02-0412v1
102/10/3727    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, D. J.
Right arrow Articles by Koeffler, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, D. J.
Right arrow Articles by Koeffler, H. P.
Related Collections
Right arrow Apoptosis
Right arrow Oncogenes and Tumor Suppressors
Right arrow Signal Transduction
Right arrow Gene Expression
Right arrow Genomics
Right arrow Hematopoiesis and Stem Cells
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Comparative analysis of genes regulated by PML/RAR{alpha} and PLZF/RAR{alpha} in response to retinoic acid using oligonucleotide arrays

Dorothy J. Park, Peter T. Vuong, Sven de Vos, Dan Douer, and H. Phillip Koeffler

From the Division of Hematology/Oncology, Cedars-Sinai Medical Center, University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, CA; Division of Hematology/Oncology, Center for Health Sciences, UCLA School of Medicine, Los Angeles, CA; Division of Hematology, University of Southern California (USC)/Norris Comprehensive Cancer Center, Keck School of Medicine, USC, Los Angeles, CA.

Acute promyelocytic leukemia (APL) is associated with chromosomal translocations involving retinoic acid receptor {alpha} (RAR{alpha}) and its fusion partners including promyelocytic leukemia (PML) and promyelocytic leukemia zinc finger (PLZF). Using oligonucleotide arrays, we examined changes in global gene expression mediated by the ectopic expression of either PML/RAR{alpha} (retinoid-sensitive) or PLZF/RAR{alpha} (retinoid-resistant) in U937 cells. Of more than 5000 genes analyzed, 16 genes were commonly up-regulated, and 57 genes were down-regulated by both fusion proteins suggesting their role in the APL phenotype. In our APL model, for example, TNFAIP2, TNFR2, ELF4, RAR{gamma}, and HoxA1 were down-regulated by both fusion proteins in the absence of retinoic acid (RA). RA strongly up-regulated these genes in PML/RAR{alpha}, but not in PLZF/RAR{alpha} expressing U937 cells. Expression studies in NB4, retinoid-resistant NB4-R2, normal human CD34+ cells, and APL patient samples strongly suggest their role in the regulation of granulocytic differentiation. Furthermore, combined treatment with tumor necrosis factor {alpha} (TNF{alpha}) and RA synergistically enhanced granulocytic differentiation in NB4 cells but not in NB4-R2 cells. Our data indicate that APL pathogenesis and retinoid-induced granulocytic differentiation of APL cells involve genes in the cell death pathway, and that cooperation between the RA and TNF{alpha} signaling pathways exists. Targeting both the retinoid-dependent differentiation and the cell death pathways may improve leukemic therapy, especially in retinoid-resistant acute myeloid leukemia. (Blood. 2003;102:3727-3736)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. Hoemme, A. Peerzada, G. Behre, Y. Wang, M. McClelland, K. Nieselt, M. Zschunke, C. Disselhoff, S. Agrawal, F. Isken, et al.
Chromatin modifications induced by PML-RAR{alpha} repress critical targets in leukemogenesis as analyzed by ChIP-Chip
Blood, March 1, 2008; 111(5): 2887 - 2895.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Witcher, F. Pettersson, D. Dupere-Richer, A. Padovani, L. Summers-Deluca, A. S. Baldwin, and W. H. Miller Jr
Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter
Nucleic Acids Res., February 2, 2008; 36(2): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Yoshida, H. Ichikawa, Y. Tagata, T. Katsumoto, K. Ohnishi, Y. Akao, T. Naoe, P. P. Pandolfi, and I. Kitabayashi
PML-Retinoic Acid Receptor {alpha} Inhibits PML IV Enhancement of PU.1-Induced C/EBP{varepsilon} Expression in Myeloid Differentiation
Mol. Cell. Biol., August 15, 2007; 27(16): 5819 - 5834.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Reineke, H. Liu, M. Lam, Y. Liu, and H.-Y. Kao
Aberrant Association of Promyelocytic Leukemia Protein-Retinoic Acid Receptor-{alpha} with Coactivators Contributes to Its Ability to Regulate Gene Expression
J. Biol. Chem., June 22, 2007; 282(25): 18584 - 18596.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Yuan, J. E. Payton, M. S. Holt, D. C. Link, M. A. Watson, J. F. DiPersio, and T. J. Ley
Commonly dysregulated genes in murine APL cells
Blood, February 1, 2007; 109(3): 961 - 970.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Liu, C. V. Hedvat, S. Mao, X.-H. Zhu, J. Yao, H. Nguyen, A. Koff, and S. D. Nimer
The ETS Protein MEF Is Regulated by Phosphorylation-Dependent Proteolysis via the Protein-Ubiquitin Ligase SCFSkp2
Mol. Cell. Biol., April 15, 2006; 26(8): 3114 - 3123.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. Bullinger and P. J.M. Valk
Gene Expression Profiling in Acute Myeloid Leukemia
J. Clin. Oncol., September 10, 2005; 23(26): 6296 - 6305.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Walter, J. S. Park, R. E. Ries, S. K. M. Lau, M. McLellan, S. Jaeger, R. K. Wilson, E. R. Mardis, and T. J. Ley
Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RAR{alpha}
PNAS, August 30, 2005; 102(35): 12513 - 12518.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Di Croce
Chromatin modifying activity of leukaemia associated fusion proteins
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R77 - R84.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
L. Li, J. Roden, B. E. Shapiro, B. J. Wold, S. Bhatia, S. J. Forman, and R. Bhatia
Reproducibility, Fidelity, and Discriminant Validity of mRNA Amplification for Microarray Analysis from Primary Hematopoietic Cells
J. Mol. Diagn., February 1, 2005; 7(1): 48 - 56.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. A. Lane and T. J. Ley
Neutrophil Elastase Is Important for PML-Retinoic Acid Receptor {alpha} Activities in Early Myeloid Cells
Mol. Cell. Biol., January 1, 2005; 25(1): 23 - 33.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. J. Walter, J. S. Park, S. K. M. Lau, X. Li, A. A. Lane, R. Nagarajan, W. D. Shannon, and T. J. Ley
Expression Profiling of Murine Acute Promyelocytic Leukemia Cells Reveals Multiple Model-Dependent Progression Signatures
Mol. Cell. Biol., December 15, 2004; 24(24): 10882 - 10893.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Gery, D. J. Park, P. T. Vuong, D. Y. Chih, N. Lemp, and H. P. Koeffler
Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes
Blood, December 15, 2004; 104(13): 3911 - 3917.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Nouzova, N. Holtan, M. M. Oshiro, R. B. Isett, J. L. Munoz-Rodriguez, A. F. List, M. L. Narro, S. J. Miller, N. C. Merchant, and B. W. Futscher
Epigenomic Changes during Leukemia Cell Differentiation: Analysis of Histone Acetylation and Cytosine Methylation Using CpG Island Microarrays
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 968 - 981.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. R. Walkley, L. E. Purton, H. J. Snelling, Y.-D. Yuan, H. Nakajima, P. Chambon, R. A. S. Chandraratna, and G. A. McArthur
Identification of the molecular requirements for an RAR{alpha}-mediated cell cycle arrest during granulocytic differentiation
Blood, February 15, 2004; 103(4): 1286 - 1295.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020